chr19-17825424-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000215.4(JAK3):​c.*1319G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 218,150 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 29 hom., cov: 32)
Exomes 𝑓: 0.012 ( 6 hom. )

Consequence

JAK3
NM_000215.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.54

Publications

5 publications found
Variant links:
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
  • T-B+ severe combined immunodeficiency due to JAK3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-17825424-C-T is Benign according to our data. Variant chr19-17825424-C-T is described in ClinVar as [Benign]. Clinvar id is 891136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0138 (2098/152160) while in subpopulation NFE AF = 0.0215 (1465/67996). AF 95% confidence interval is 0.0206. There are 29 homozygotes in GnomAd4. There are 959 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 29 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAK3NM_000215.4 linkc.*1319G>A 3_prime_UTR_variant Exon 24 of 24 ENST00000458235.7 NP_000206.2 P52333-1A0A024R7M7
JAK3NM_001440439.1 linkc.*1319G>A 3_prime_UTR_variant Exon 24 of 24 NP_001427368.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAK3ENST00000458235.7 linkc.*1319G>A 3_prime_UTR_variant Exon 24 of 24 5 NM_000215.4 ENSP00000391676.1 P52333-1
JAK3ENST00000696967.1 linkn.3871G>A non_coding_transcript_exon_variant Exon 19 of 19
JAK3ENST00000696968.1 linkn.1927G>A non_coding_transcript_exon_variant Exon 3 of 3
JAK3ENST00000527031.5 linkn.2279-114G>A intron_variant Intron 13 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2098
AN:
152042
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00447
Gnomad AMI
AF:
0.0407
Gnomad AMR
AF:
0.00833
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.0219
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.00669
GnomAD4 exome
AF:
0.0123
AC:
814
AN:
65990
Hom.:
6
Cov.:
0
AF XY:
0.0125
AC XY:
384
AN XY:
30620
show subpopulations
African (AFR)
AF:
0.00201
AC:
6
AN:
2992
American (AMR)
AF:
0.00725
AC:
14
AN:
1930
Ashkenazi Jewish (ASJ)
AF:
0.00429
AC:
18
AN:
4196
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9672
South Asian (SAS)
AF:
0.00172
AC:
1
AN:
580
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52
Middle Eastern (MID)
AF:
0.00248
AC:
1
AN:
404
European-Non Finnish (NFE)
AF:
0.0175
AC:
713
AN:
40628
Other (OTH)
AF:
0.0110
AC:
61
AN:
5536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0138
AC:
2098
AN:
152160
Hom.:
29
Cov.:
32
AF XY:
0.0129
AC XY:
959
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00446
AC:
185
AN:
41518
American (AMR)
AF:
0.00832
AC:
127
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4824
European-Finnish (FIN)
AF:
0.0219
AC:
232
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0215
AC:
1465
AN:
67996
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
106
212
318
424
530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0145
Hom.:
2
Bravo
AF:
0.0125
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

T-B+ severe combined immunodeficiency due to JAK3 deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.30
DANN
Benign
0.59
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118101939; hg19: chr19-17936233; API